Assay Biology & Screening Services

Assay development, screening, and mechanism studies, scoped to your biological question

Explore

Flexible scientific support built around your preclinical problem

FDA's March 2026 NAM guidance set four bars for non-animal models: context of use, human biological relevance, technical characterization, and fit-for-purpose. That's the standard we build to — for cosmetic efficacy claims, nutraceutical bioactivity studies, and early discovery programs alike.

We take projects at any stage: a custom experimental strategy, proof-of-concept data, assay development, or full study execution through to a recommendation.

Flexible scientific support built around your preclinical problem
scientist.com

Capabilities

Operating out of a 5,000 sq. ft. GMP-compliant facility, YBL-IDD delivers robust, high-throughput assay biology services powered by state-of-the-art screening and analytical infrastructure. Our multidisciplinary team of 15+ PhDs and Master’s-level scientists brings over 50 years of combined industry experience across pharmacology, cell biology, and assay development. From custom biochemical screenings to complex phenotypic readouts, we translate biological complexity into reproducible, decision-ready preclinical data.

Cell & Molecular Biology

Cell & Molecular Biology

Mammalian, Primary cell, and iPSC culture; DNA/RNA extraction, PCR/qPCR, RT-PCR, gene expression

Biochemistry

Biochemistry

Western blot, ELISA, Immunohistochemistry

Screening & Toxicology

Screening & Toxicology

Dose-response, IC50, drug synergy, hepatotoxicity, oxidative stress, mitochondrial toxicity, viability, cytotoxicity, ROS, apoptosis

Discovery Biology

Discovery Biology

mechanism of action, biomarker evaluation studies

In-house Instrumentation

In-house Instrumentation

RT-PCR, High-content imaging system, Flow cytometer, Multi-mode plate reader, Western blot, paraffin embedding & sectioning

ISO Certification

ISO Certification

ISO 9001, 13495, 45001 and 27001


Before You Start

Tell us the biological question you're trying to answer and, if you have one, the endpoint you're working toward. We'll scope a timeline once we know the compound number, timepoints, and assay complexity — we don't quote a generic figure upfront.

scientist.com
Speak with a Scientist